SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in FBRX — Forte Biosciences, Inc.

CIK 1446194 BALA CYNWYD, PA

Back to FBRX Full portfolio

Position in FBRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,457,494

+$2,014,530 QoQ

Shares Held

133,494

+152.3% QoQ

Ownership

0.961%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#19

of 68 holders

Holding Since

Sep 2024

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in FBRX Over Time

Shares Held

Position Value (USD)

Derivatives in FBRX

reported options exposure · as of Mar 31, 2026

CallValue

$890,960

CallShares

34,400

PutValue

$593,110

PutShares

22,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,173,997,525 across 354 Biotechnology names. FBRX ranks #74 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	898,951	$59,249,860
2	ALNY	Alnylam Pharmaceuticals, Inc.	174,268	$57,660,053
3	AGIO	Agios Pharmaceuticals, Inc.	1,344,953	$45,499,759
4	ABVX	Abivax S.A.	381,282	$42,455,750
5	BBIO	BridgeBio Pharma, Inc.	398,943	$29,625,507
6	INSM	INSMED Inc	173,630	$28,391,977
7	CRSP	CRISPR Therapeutics AG	593,406	$28,228,323
8	TERN	Terns Pharmaceuticals, Inc.	521,571	$27,497,223

All Filings in FBRX

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$593,110	22,900	-82.8%	Put	Other	2026-05-15
2026-03-31	$3,457,494	133,494	+288.1%	Shares	Other	2026-05-15
2026-03-31	$890,960	34,400	-35.0%	Call	Other	2026-05-15
2025-12-31	$1,442,964	52,914	+304.0%	Shares	Other	2026-02-17
2024-09-30	$73,206	13,096	—	Shares	Defined	2024-11-14
No filing history on record for this holder in this stock.